Division of Molecular Medicine and Gene Therapy
41 – 60 of 567
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
The 2022 International Society for Stem Cell Research (ISSCR) Annual Meeting : Celebrating 20 Years of Achievements
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Nuclear stabilization of p53 requires a functional nucleolar surveillance pathway
(
- Contribution to journal › Article
-
Mark
FOXO1 regulates pentose phosphate pathway-mediated induction of developmental erythropoiesis
(
- Contribution to journal › Article
-
Mark
Small Molecules Pushing Erythroid/Megakaryocyte Cell Specification Boundaries
(
- Contribution to journal › Article
-
Mark
Schlafen2 is a regulator of quiescence in adult murine hematopoietic stem cells
(
- Contribution to journal › Article
-
Mark
Inflammatory Alveolar Type 2 Cells in Chronic Obstructive Pulmonary Disease : Impairing or Improving Disease Outcome?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Targeting elevated heme levels to treat a mouse model for Diamond-Blackfan Anemia
(
- Contribution to journal › Article
-
Mark
Genome-wide association study on 13 167 individuals identifies regulators of blood CD34+cell levels
(
- Contribution to journal › Article
-
Mark
Inducing synthetic lethality for selective targeting of acute myeloid leukemia cells harboring STAG2 mutations
(
- Contribution to journal › Letter
-
Mark
Small Molecule Screening of Primary Human Acute Myeloid Leukemia Using Co-culture and Multiplexed FACS Analysis
(
- Contribution to journal › Article
-
Mark
Reprogramming Stars #6 : A Venture Based in Cellular Reprogramming-An Interview with Dr. Cristiana Pires
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Reprogramming Stars #5 : Regeneration, a Natural Reprogramming Process-An Interview with Dr. Nicholas Leigh
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Compositions, constructs and vectors for cell reprogramming (NK cell reprogramming).
2022) WO2022129542(
- Patent › Patent
-
Mark
A somatic mutation in moesin drives progression into acute myeloid leukemia
(
- Contribution to journal › Article
-
Mark
Establishment of an immortalized human erythroid cell line sustaining differentiation potential without inducible gene expression system
(
- Contribution to journal › Article
-
Mark
Eliciting Anti-Tumor Immunity by Reprogramming Cancer Cells to Type 1 Conventional Dendritic Cells
2022) European Association for Cancer Research 2022 - Congress(
- Contribution to conference › Poster
-
Mark
Harnessing Dendritic Cell Reprogramming to Elucidate Mechanisms of Tumor Immunity
2022) Lund Stem Cell Center Retreat(
- Contribution to conference › Poster
-
Mark
Modeling normal and malignant hematopoiesis in vitro. To screen for extrinsic regulators and differentiation therapy.
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Cell-type profiling in salamanders identifies innovations in vertebrate forebrain evolution
(
- Contribution to journal › Article
-
Mark
Concurrent stem- and lineage-affiliated chromatin programs precede hematopoietic lineage restriction
(
- Contribution to journal › Article